Fuse Medical, Inc., (OTC PINK: FZMD), (“Fuse” or the “Company”), announced that OTC Markets has identified Fuse as “Penny Stock Exempt,” meaning that shares of Fuse’s common stock, par value $0.01 per share (the “Common Stock”), is no longer a “Penny Stock” as defined in Rule 3a51-1, promulgated under the Securities Exchange Act of 1934, as amended.

To qualify as “Penny Stock Exempt” on the OTC Markets, an issuer must satisfy one of the following requirements: (i) the issuer’s securities have a minimum price greater than $5 per share; (ii) the issuer has average revenues of at least $6 million for the last three (3) years; or (iii) the issuer has net tangible assets exceeding $2 million, if the issuer has been in continuous operations for at least three (3) years or $5 million if less than three (3) years.

“We are very pleased that OTC Markets has identified our Common Stock as exempt from the Penny Stock designation on the OTC Pink markets,” Christopher C. Reeg, Chief Executive Officer of Fuse, said. “With this exemption, national broker/dealers may freely recommend our Common Stock to their clients. We anticipate that this news may generate greater interest in our Company.”

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment